Gotowe bibliografie tematyczne / Cerebrovascular disease

Gotowa bibliografia na temat „Cerebrovascular disease”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 3 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cerebrovascular disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cerebrovascular disease"

1

Gorelick, Philip B. "Cerebrovascular Disease". Nursing Clinics of North America 21, nr 2 (czerwiec 1986): 275–88. http://dx.doi.org/10.1016/s0029-6465(22)00416-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Wolf, P. A., i J. C. Grotta. "Cerebrovascular Disease". Circulation 102, Supplement 4 (14.11.2000): IV—75—IV—80. http://dx.doi.org/10.1161/01.cir.102.suppl_4.iv-75.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Frost, Elizabeth A. M. "Cerebrovascular disease". Current Opinion in Anaesthesiology 4, nr 5 (październik 1991): 639–44. http://dx.doi.org/10.1097/00001503-199110000-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Herrick, Ian A. "Cerebrovascular disease". Current Opinion in Anaesthesiology 16, nr 3 (czerwiec 2003): 337–42. http://dx.doi.org/10.1097/00001503-200306000-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Caprio, Fan Z., i Farzaneh A. Sorond. "Cerebrovascular Disease". Medical Clinics of North America 103, nr 2 (marzec 2019): 295–308. http://dx.doi.org/10.1016/j.mcna.2018.10.001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Holloway, R. G. "Cerebrovascular Disease". Neurology 49, nr 4 (1.10.1997): 1192. http://dx.doi.org/10.1212/wnl.49.4.1192.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Sacco, Ralph L., i Tatjana Rundek. "Cerebrovascular disease". Current Opinion in Neurology 25, nr 1 (luty 2012): 1–4. http://dx.doi.org/10.1097/wco.0b013e32834f89b1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Caplan, Louis R., D. Eric Searls i Fong Kwong Sonny Hon. "Cerebrovascular Disease". Medical Clinics of North America 93, nr 2 (marzec 2009): 353–69. http://dx.doi.org/10.1016/j.mcna.2008.09.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Bowsher, David, G. Vantrappen, David Mabey, Tom Treasure, KentL Woods, WilliamP Arend i David Bowsher. "CEREBROVASCULAR DISEASE". Lancet 341, nr 8838 (styczeń 1993): 156. http://dx.doi.org/10.1016/0140-6736(93)90015-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Bonita, Ruth, i Robert Beaglehole. "CEREBROVASCULAR DISEASE". Lancet 341, nr 8859 (czerwiec 1993): 1510–11. http://dx.doi.org/10.1016/0140-6736(93)90640-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Cerebrovascular disease"

1

Holt, Jim, i Gregg Mitchell. "Cerebrovascular Disease KSA". Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/etsu-works/6458.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Murphy, Jeremy James. "Clinical trials in cerebrovascular disease". Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293328.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Man, Lai-mei. "An exploratory study for the health seeking pattern of stroke survivors on alternative medicine". Hong Kong : University of Hong Kong, 1998. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20133236.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Williams, David James. "Near infrared spectroscopy in cerebrovascular disease". Thesis, University of Bath, 2002. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426180.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Hoffmann, Tammy Coral. "Development and evaluation of a computer-generated individualised written education package for patients following stroke and their carers /". [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18924.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Wan, Wai-kuen Christina. "An exploratory design of an empowerment group for the stroke survivors". Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19469937.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Li, Sijian. "Evaluating the effectiveness of a stroke education programme in Wuhan City of China /". Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20793224.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Fung, Mei-ling. "Stroke rehabilitation : predicting LOS and discharge placement /". Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25101298.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Gibbs, Richard Geoffrey James. "The aetiology and epidemiology of cerebrovascular disease". Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405270.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Chan, Chi-wing Martin. "Is bilateral isokinematic training (BIT) more effective than unilateral limb training in improving the hemiplegic upper-limb function /". View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30469697.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Cerebrovascular disease"

1

Vladimir, Hachinski, red. Cerebrovascular disease. London: Baillière Tindall, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Hunt, Batjer H., red. Cerebrovascular disease. Philadelphia: Lippincott-Raven, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

1924-, Kameyama Masakuni, Tomonaga Masanori i Aiba Tadashi, red. Cerebrovascular disease. Tokyo: Igaku-Shoin, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

L, Babikian Viken, Wechsler Lawrence R i Higashida Randall T, red. Imaging cerebrovascular disease. Philadelphia: Butterworth-Heinemann, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

S, Moore Wesley, red. Surgery for cerebrovascular disease. Wyd. 2. Philadelphia: W.B. Saunders, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

B, Gorelick Philip, red. Atlas of cerebrovascular disease. Philadelphia: Current Medicine, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

B, Gorelick Philip, i Sloan Michael A, red. Atlas of cerebrovascular disease. Wyd. 2. Philadelphia: Current Medicine, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

J, Alberts Mark, red. Genetics of cerebrovascular disease. Armonk, NY: Futura Pub. Co., 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

S, Moore Wesley, red. Surgery for cerebrovascular disease. New York: Churchill Livingstone, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

M, Sundt Thoralf, i Meyer Fredric B, red. Sundt's Occlusive cerebrovascular disease. Wyd. 2. Philadelphia, PA: W.B. Saunders, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Cerebrovascular disease"

1

Wagle, Kamal C. "Cerebrovascular Disease". W Family Medicine, 837–49. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_72.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Gerhard-Herman, Marie, i Aaron Aday. "Cerebrovascular Disease". W Manual of Vascular Medicine, 63–72. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44715-1_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Roth, Elliot J. "Cerebrovascular Disease". W Encyclopedia of Clinical Neuropsychology, 740–41. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2167.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Patel, Sheela T., i K. Craig Kent. "Cerebrovascular Disease". W Surgery, 1005–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-57282-1_45.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Roth, Elliot J. "Cerebrovascular Disease". W Encyclopedia of Clinical Neuropsychology, 536. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2167.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

McCabe, Melvina. "Cerebrovascular Disease". W Family Medicine, 557–64. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_65.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Orsini, Donna L., Wilfred G. van Gorp i Kyle B. Boone. "Cerebrovascular Disease". W The Neuropsychology Casebook, 40–68. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3836-2_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Fowler, T. J., i R. W. May. "Cerebrovascular Disease". W Neurology, 115–24. Dordrecht: Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-010-9544-0_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Roth, Elliot J. "Cerebrovascular Disease". W Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2167-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

McCabe, Melvina L. "Cerebrovascular Disease". W Family Medicine, 494–501. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_65.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Cerebrovascular disease"

1

Axelerad, Docu Any, Daniel Docu-Axelerad i Valentin Negrea. "Smoking and the Cerebrovascular Disease". W DIALOGO-CONF 2018 OVERPOPULATION AND RELIGION's INVOLMENT (ORI). EDIS - Publishing Institution of the University of Zilina, Slovak Republic, 2018. http://dx.doi.org/10.18638/dialogo.2018.4.2.9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Estévez, M., A. Argibay, L. Rodriguez, M. Freire, B. Gimena, J. Fernández-Martín i A. Rivera. "FRI0289 Cerebrovascular disease in the antiphospholipid syndrome". W Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4509.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Gramasco, Hendrick Henrique Fernandes, Mateus Felipe dos Santos, Yasmim Nadime José Frigo, Guilherme Drumond Jardini Anastácio, Stella de Angelis Trivellato, Daniel Fabiano Barbosa dos Santos, Ana Cláudia Pires Carvalho i in. "Diverse clinical presentations of Moyamoya disease: a case series". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.530.

Pełny tekst źródła
Streszczenie:
Context: Moyamoya disease or chronic occlusive cerebrovascular disease is characterized by proximal occlusion of the internal carotid artery and its branches bilaterally, generating an angiographic “smoke” pattern (moyamoya, from Japanese “something hazy”) and by diverse ischemic manifestations. Case report: The sample consists of three female patients, aged between 13 and 46 years, followed in our service due to the diagnosis of Moyamoya Disease. Among the clinical manifestations presented, ischemic cerebrovascular events with neurological deficit predominated, and one of the patients presented two episodes compatible with stroke and one episode compatible with transient ischemic accident. The youngest patient presented with a choreic picture initially interpreted as Sydenham’s chorea. Although the gold standard for the diagnosis of chronic occlusive cerebrovascular disease is cerebral arterial angiography, it was possible to observe a pattern compatible with the disease in other modalities of examination, such as cerebral arterial angiotomography and cerebral arterial angioresonance. From the therapeutic point of view, one of the patients underwent surgical intervention (encephaloduromyosinangiosis), with improvement of symptoms after treatment. Conclusions: In this paper, we emphasize the importance of complementary imaging tests in the evaluation of patients with cerebrovascular syndromes and the diversity of clinical presentation of Moyamoya disease.
Style APA, Harvard, Vancouver, ISO itp.
4

Martins, Karine Felipe, Flávia Pascoal Teles, Amanda Fernandes de Sousa Oliveira Balestra i Isadora Rosa Maia. "Cerebrovascular diseases: the importance of recognizing them". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.188.

Pełny tekst źródła
Streszczenie:
Background: Until the 70s, cerebrovascular diseases (CVDs) were neglected to the lack of resources. However, due to the advancement of technology, several imaging tests have appeared, such as magnetic resonance and computed tomography, which facilitated the diagnosis and the understanding of the pathophysiology of each disease. Objectives: The objective of this work is to identify the main CVDs signs and symptoms. Methods: An integrative literature review was carried out based on selected articles from Google Scholar, PubMed and SciELO, using the terms headache, cerebrovascular disease, neurology. Results: CVDs are characterized by causing damage to brain vessels, due to changes in blood flow momentarily or permanently in an area of the brain, allowing them to be classified as ischemic or hemorrhagic. In ischemic there is a blockage of blood flow and, consequently, of oxygen to areas of the brain, in hemorrhagic rupture of a vessel occurs and, with this, blood leakage. Therefore, it is necessary to recognize the signs and symptoms early, in order to prevent loss of neurological function, movements on one side of the body and the presence or absence of headaches in both patients, with ischemic CVD and hemorrhagic CVD prevent rapid loss of consciousness accompanied by severe headache. Such signs and symptoms associated with the patient’s family history and lifestyle can help in the diagnosis of this disease. Conclusion: Therefore, it is important to recognize the signs and symptoms of CVDs, in order to determine the treatment and advise the patient, which will guarantee a better prognosis.
Style APA, Harvard, Vancouver, ISO itp.
5

Qiang Sun, Qiang, Jiang Jiang Yuan i Lei Lei Zeng. "Interventional Therapy of Cerebrovascular Disease Mechanical Embolic Materials". W 2015 International Conference on Mechanical Science and Engineering. Paris, France: Atlantis Press, 2016. http://dx.doi.org/10.2991/mse-15.2016.8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Oliveira, Francisco Gabriel Cabral, Juliana Paiva Ribeiro Moura, Matheus Henrique Oliveira i Mylena Teles de Jesus. "The relation between COVID-19 and cerebrovascular diseases". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.740.

Pełny tekst źródła
Streszczenie:
Introduction: Covid-19 is characterized by respiratory syndrome and has symptoms that affect the central nervous system such as headache, anosmia, hypercoagulability, etc. In this sense, it is known that the virus shows tropism by the receptors of the angiotensin-converting enzyme 2 (ACE2), becoming a gateway to the neurological system, which can cause complications. Is to relate the infection by COVID-19 and the increase in cerebrovascular diseases. Methods: A literature review was carried out using search for scientific articles in PubMed, in April / 2021, with a filter in the last 5 years, using the descriptors “Covid”, “Cerebrovascular Diseases” and “Man” associated with the Boolean operator AND. Results: 53 articles were found, of which 19 were selected for research. There is a higher frequency of neurological symptoms in patients with COVID-19 than in patients without the disease. The effect of binding the virus to ACE2 receptors is to activate a cascade of cytokines, which tends to lead to serious complications. For this reason, severe coagulopathies can be caused, increasing products of the degradation of C-reactive protein, D Dimer, fibrinogen and thrombocytopenia. The increase in cerebrovascular events also occurs because the antithrombotic, neuroprotective, antihypertensive effects, among others, of the alternative renin-angiotensin system in the brain are interrupted due to COVID-19. Conclusion: It was seen that cerebrovascular events are related to the course of COVID-19, in which patients may develop several serious complications, such as encephalitis, strokes and vascular thrombosis. Thus, the pathophysiology of this disease is related to an inflammatory process.
Style APA, Harvard, Vancouver, ISO itp.
7

Rahman, G. M. Mahmudur, H. Okazawa, Md Sherajul Islam, Md Shahjahan i S. S. Zakir. "Probing the neuronal status for cerebrovascular disease using EEG". W 2017 International Conference on Electrical, Computer and Communication Engineering (ECCE). IEEE, 2017. http://dx.doi.org/10.1109/ecace.2017.7912926.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

SOSSI, VESNA. "PET for cerebrovascular diseases: status and limitation". W Frontiers in Imaging Science: High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart). Trieste, Italy: Sissa Medialab, 2008. http://dx.doi.org/10.22323/1.039.0017.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Mesquita, Rodrigo da Rosa, Tatiana Farias de Oliveira, Gibson Barros de Almeida Santana, Antônio Leopoldo do Nascimento Gama Albuquerque, Amanda Karine Barros Ferreira Rodrigues i Carlos Dornels Freire de Souza. "Epidemiological profile and temporal trend of mortality from cerebrovascular diseases in Northeast of Brazil, 1996-2016". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.600.

Pełny tekst źródła
Streszczenie:
Background: Cerebrovascular diseases represent the second leading cause of mortality in the world and Brazil occupies the leadership in the ranking of mortality in South America. Objectives: This study sought to analyze the sociodemographic profile and the time trend of the mortality rate from cerebrovascular disease in the Northeast of Brazil, 1996-2016. Methods: This is an ecological study of time series involving deaths from cerebrovascular diseases in the Northeastern of Brazil, 1996-2016. Sociodemographic variables (age, schooling, marital status, skin color, ICD category and federation units) were included and calculated crude and standardized mortality rates, according to gender and age group. A joinpoint regression model was applied for the temporal analysis, with a level of significance of 5%. Results: There were 490.433 deaths from cerebrovascular diseases in the Northeast of Brazil, 1996-2016. Of these deaths, 50,03% (n = 245.354) were women, 79,72% (n = 390.957) elderly, 46,66% (n = 228.851) brown, 51,81% (n = 332.439) illiterate and 37,93% (n = 186.014) were married. Of the causes of death, 56,63% (n = 277.741) resulted from stroke, not specified as hemorrhagic or ischemic (I64). In the Northeast, there was a predominance of the elderly population, with growth of 1.2% (p < 0.001). Conclusions: Standardized mortality increased in four states, being higher in Maranhão and Piauí, with a predominance of females and age equal to or above 60 years.
Style APA, Harvard, Vancouver, ISO itp.
10

Mou, Xiao, Xingce Wang, Zhongke Wu, Xuesong Wang i Mingquan Zhou. "An automatic eHealth platform for cardiovascular and cerebrovascular disease detection". W 2015 International Symposium on Bioelectronics and Bioinformatics (ISBB). IEEE, 2015. http://dx.doi.org/10.1109/isbb.2015.7344924.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Cerebrovascular disease"

1

Chen, Qian, i Qinhao Wang. The neuroprotective effect of edaravone dexborneol in cerebrovascular disease: a comprehensive systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0069.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Roldán-González, Elizabeth, Carolina Robledo-Castro, Piedad Rocío Lerma-Castaño i María Luisa Hurtado-Otero. Validity and reliability of the Wolf Motor Function Test -WMFT in patients with Cerebrovascular disease: Scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0044.

Pełny tekst źródła
Streszczenie:
Review question / Objective: This scoping review aimed to compile the studies that have examined the validity and reliability of the different versions of the Wolf Motor Function Test - WMFT in patients with Cerebrovascular disease. Background: Numerous investigations in rehabilitation have used the WMFT as an instrument for the primary measurement of the results; however, to date, there are no known reviews that have compiled the reliability and validity of the wolf test in its different versions, which is considered of vital importance and constitutes critical information for decision making in the process of evaluation and follow-up of patients with stroke in clinical, academic and research environments.
Style APA, Harvard, Vancouver, ISO itp.
3

Hu, XinYi, JingXuan Hao i HangYue Wang. Improvement of Environmental enrichment on Cognitive Functions in Patients and animals : A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, grudzień 2022. http://dx.doi.org/10.37766/inplasy2022.12.0014.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To study the relationship between environmental enrichment and cognitive function through a meta-analysis of the literature, analyze its effects on the improvement of cognitive function in patients and animals, and evaluate the effects of different environmental enrichment measures on cognitive function improvement. Condition being studied: Cognitive decline refers to an individual's memory, language, reasoning and other aspects of cognitive function showing obvious, measurable decline or abnormal. The causes of cognitive decline are various, including neurodegeneration, cerebrovascular disease, infection, trauma, and depression. Alzheimer's disease and stroke are the most common.
Style APA, Harvard, Vancouver, ISO itp.
4

LI, Peng, i Junjun Liu. Effect of statin therapy on moderate-to-severe depression: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0016.

Pełny tekst źródła
Streszczenie:
Review question / Objective: We aim to assess the antidepressant effects of statin therapy among patients complicated with moderate to severe depression. Condition being studied: Depression is one of the major causes of disability worldwide, and major depressive disorders (MDD) contribute to a significant heavy disease burden, which is expected to be second by 2050, only to heart disease. Despite great improvement in therapy, the treatment efficacy remains low. Therefore, alternative therapies have been intensely investigated. A substantial body of researches have suggested that inflammation is one of the operative pathways between MDD and increased risk of somatic comorbidities, and some specific depressive symptoms. Depression occurs in most patients with cardiac and cerebrovascular disease due to the long-term effects, and depression increases the risk of cardiovascular disease in the population as a whole and in patients with coronary artery disease or stroke. Several observational studies have demonstrated reduced rates of depression among patients taking statins, which may be related to its anti-inflammatory effect. However, whether statin improves the depressive symptoms and its associated mechanism is still mixed. Furthermore, there is little evidence about statin treatment effect in those with moderate to severe depression. In addition, whether the effect of statin treatment on depressive symptom changes with time or is affected by baseline depression severity or percentage change of lipid levels has not been explored in previous studies.
Style APA, Harvard, Vancouver, ISO itp.
5

Li, Tian, Shanshan Jin, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin i in. Metformin may reduce the mortality and cardiac events in patients with cardio-cerebrovascular diseases, irrespective of concurrent diabetes: a meta-analysis of randomized controlled trails and cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, czerwiec 2020. http://dx.doi.org/10.37766/inplasy2020.6.0008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Cerebrovascular disease” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii